Literature DB >> 33029949

Facial disfigurement due to olfactory neuroblastoma: beauty regained with chemotherapy.

Parmod Kumar1, Deepak Sundriyal1, Rekha Bhandari2, Abhijeet Singh3, Bhinyaram Jat3, Amit Sehrawat1.   

Abstract

BACKGROUND: Olfactory neuroblastoma (ONB) is a sinonasal malignancy seldom seen in clinical practice. It is also known by various other names like esthesioneuroblastoma, esthesioneuroepithelioma, esthesioneurocytoma, and esthesioneuroma. Surgery and radiation therapy are considered as standard treatment modalities for ONB; however, the role of chemotherapy is not well established. AIMS: We aim to define the role of chemotherapy in the neoadjuvant setting in a case of ONB. METHODS AND
RESULTS: We report a young female patient presenting with a naso-facial swelling causing facial disfigurement, proptosis, decreased visual acuity, and poor performance status. She was diagnosed with advanced-stage ONB. Prompt administration of chemotherapy led to the improvement in the symptoms and rapid regression of the tumor mass. Later on, the tumor mass was excised completely without any neurological deficit.
CONCLUSION: This report justifies the role of neoadjuvant chemotherapy in the management of ONB.
© 2020 The Authors. Cancer Reports published by Wiley Periodicals LLC.

Entities:  

Keywords:  chemosensitive; neoadjuvant chemotherapy; olfactory neuroblastoma

Year:  2020        PMID: 33029949      PMCID: PMC7941440          DOI: 10.1002/cnr2.1303

Source DB:  PubMed          Journal:  Cancer Rep (Hoboken)        ISSN: 2573-8348


  14 in total

1.  Olfactory neuroblastoma. A clinical analysis of 17 cases.

Authors:  S Kadish; M Goodman; C C Wang
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

Review 2.  Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system.

Authors:  Rami E Saade; Ehab Y Hanna; Diana Bell
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

3.  Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.

Authors:  Diana Bell; Rami Saade; Dianna Roberts; Thomas J Ow; Michael Kupferman; Franco DeMonte; Ehab Y Hanna
Journal:  Head Neck Pathol       Date:  2014-05-08

4.  Chemotherapy in Esthesioneuroblastoma/Olfactory Neuroblastoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) 1973-2015 Database.

Authors:  Lee D Cranmer; Bonny Chau; Jason K Rockhill; Manuel Ferreira; Jay J Liao
Journal:  Am J Clin Oncol       Date:  2020-03       Impact factor: 2.339

5.  Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis.

Authors:  John P Marinelli; Jeffrey R Janus; Jamie J Van Gompel; Michael J Link; Robert L Foote; Christine M Lohse; Katharine A Price; Ashish V Chintakuntlawar
Journal:  Head Neck       Date:  2018-05-13       Impact factor: 3.147

Review 6.  Importance of neoadjuvant chemotherapy in olfactory neuroblastoma treatment: Series report and literature review.

Authors:  Ricardo Bartel; Xavier Gonzalez-Compta; Enric Cisa; Francesc Cruellas; Alberto Torres; Aleix Rovira; Manel Manos
Journal:  Acta Otorrinolaringol Esp (Engl Ed)       Date:  2017-10-20

7.  Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma.

Authors:  Xinmao Song; Jie Wang; Shengzi Wang; Li Yan; Yi Li
Journal:  Oral Oncol       Date:  2020-02-29       Impact factor: 5.337

Review 8.  Esthesioneuroblastoma: A Comprehensive Review of Diagnosis, Management, and Current Treatment Options.

Authors:  Brian Fiani; Syed A Quadri; Alessandra Cathel; Mudassir Farooqui; Anirudh Ramachandran; Imran Siddiqi; Hammad Ghanchi; Atif Zafar; Blake W Berman; Javed Siddiqi
Journal:  World Neurosurg       Date:  2019-03-09       Impact factor: 2.104

9.  Outcomes for olfactory neuroblastoma treated with induction chemotherapy.

Authors:  Shirley Y Su; Diana Bell; Renata Ferrarotto; Jack Phan; Dianna Roberts; Michael E Kupferman; Steven J Frank; C David Fuller; G Brandon Gunn; Merrill S Kies; Bonnie S Glisson; Ehab Y Hanna
Journal:  Head Neck       Date:  2017-05-31       Impact factor: 3.147

10.  Esthesioneuroblastoma: prognosis and management.

Authors:  A Morita; M J Ebersold; K D Olsen; R L Foote; J E Lewis; L M Quast
Journal:  Neurosurgery       Date:  1993-05       Impact factor: 4.654

View more
  1 in total

1.  Facial disfigurement due to olfactory neuroblastoma: beauty regained with chemotherapy.

Authors:  Parmod Kumar; Deepak Sundriyal; Rekha Bhandari; Abhijeet Singh; Bhinyaram Jat; Amit Sehrawat
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.